Cerulean Pharma Inc. (Nasdaq:CERU), a leader in Dynamic Tumor Targeting™, today announced that Christopher D. T. Guiffre, JD, MBA, Chief Operating Officer, will present at the 7th Annual BIO CEO & Investor Conference in New York on Tuesday, February 10, 2015, at 9:30 a.m. ET. Mr. Guiffre also will participate in an analyst-led fireside chat at the Leerink Partners 2015 Global Healthcare Conference in New York on Thursday, February 12, 2015, at 1:00 p.m. ET.
Help employers find you! Check out all the jobs and post your resume.
